The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Typhoid Fever Vaccines Market Research Report 2024

Global Typhoid Fever Vaccines Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1466003

No of Pages : 78

Typhoid fever is contracted by drinking or eating the Salmonella bacteria in contaminated food or water. Typhoid Fever Vaccines prevent typhoid fever and provide protection against it.

The global Typhoid Fever Vaccines market was valued at US$ 211 million in 2023 and is anticipated to reach US$ 315.8 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Typhoid Fever Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Typhoid Fever Vaccines.

Report Scope

The Typhoid Fever Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Typhoid Fever Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Typhoid Fever Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  •     Sanofi Pasteur
  •     GlaxoSmithKline
  •     Bharat Biotech
  •     PaxVax
  •     Biomed
  •     Prokarium
  •     China National Biotec Group

Segment by Type

  •     Live Attenuated Vaccine
  •     Conjugate Vaccine
  •     Capsular Polysaccharide Vaccines
  •     Others

Segment by Application

  •     Government Institution
  •     Private Sector

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Typhoid Fever Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Typhoid Fever Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

1 Typhoid Fever Vaccines Market Overview
    1.1 Product Overview and Scope of Typhoid Fever Vaccines
    1.2 Typhoid Fever Vaccines Segment by Type
        1.2.1 Global Typhoid Fever Vaccines Market Value Comparison by Type (2024-2030)
        1.2.2 Live Attenuated Vaccine
        1.2.3 Conjugate Vaccine
        1.2.4 Capsular Polysaccharide Vaccines
        1.2.5 Others
    1.3 Typhoid Fever Vaccines Segment by Application
        1.3.1 Global Typhoid Fever Vaccines Market Value by Application: (2024-2030)
        1.3.2 Government Institution
        1.3.3 Private Sector
    1.4 Global Typhoid Fever Vaccines Market Size Estimates and Forecasts
        1.4.1 Global Typhoid Fever Vaccines Revenue 2019-2030
        1.4.2 Global Typhoid Fever Vaccines Sales 2019-2030
        1.4.3 Global Typhoid Fever Vaccines Market Average Price (2019-2030)
    1.5 Assumptions and Limitations

 2 Typhoid Fever Vaccines Market Competition by Manufacturers
    2.1 Global Typhoid Fever Vaccines Sales Market Share by Manufacturers (2019-2024)
    2.2 Global Typhoid Fever Vaccines Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global Typhoid Fever Vaccines Average Price by Manufacturers (2019-2024)
    2.4 Global Typhoid Fever Vaccines Industry Ranking 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Typhoid Fever Vaccines, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Typhoid Fever Vaccines, Product Type & Application
    2.7 Typhoid Fever Vaccines Market Competitive Situation and Trends
        2.7.1 Typhoid Fever Vaccines Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Typhoid Fever Vaccines Players Market Share by Revenue
        2.7.3 Global Typhoid Fever Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Typhoid Fever Vaccines Retrospective Market Scenario by Region
    3.1 Global Typhoid Fever Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global Typhoid Fever Vaccines Global Typhoid Fever Vaccines Sales by Region: 2019-2030
        3.2.1 Global Typhoid Fever Vaccines Sales by Region: 2019-2024
        3.2.2 Global Typhoid Fever Vaccines Sales by Region: 2025-2030
    3.3 Global Typhoid Fever Vaccines Global Typhoid Fever Vaccines Revenue by Region: 2019-2030
        3.3.1 Global Typhoid Fever Vaccines Revenue by Region: 2019-2024
        3.3.2 Global Typhoid Fever Vaccines Revenue by Region: 2025-2030
    3.4 North America Typhoid Fever Vaccines Market Facts & Figures by Country
        3.4.1 North America Typhoid Fever Vaccines Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America Typhoid Fever Vaccines Sales by Country (2019-2030)
        3.4.3 North America Typhoid Fever Vaccines Revenue by Country (2019-2030)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Typhoid Fever Vaccines Market Facts & Figures by Country
        3.5.1 Europe Typhoid Fever Vaccines Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe Typhoid Fever Vaccines Sales by Country (2019-2030)
        3.5.3 Europe Typhoid Fever Vaccines Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Typhoid Fever Vaccines Market Facts & Figures by Country
        3.6.1 Asia Pacific Typhoid Fever Vaccines Market Size by Country: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific Typhoid Fever Vaccines Sales by Country (2019-2030)
        3.6.3 Asia Pacific Typhoid Fever Vaccines Revenue by Country (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Typhoid Fever Vaccines Market Facts & Figures by Country
        3.7.1 Latin America Typhoid Fever Vaccines Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America Typhoid Fever Vaccines Sales by Country (2019-2030)
        3.7.3 Latin America Typhoid Fever Vaccines Revenue by Country (2019-2030)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Typhoid Fever Vaccines Market Facts & Figures by Country
        3.8.1 Middle East and Africa Typhoid Fever Vaccines Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa Typhoid Fever Vaccines Sales by Country (2019-2030)
        3.8.3 Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2019-2030)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E

 4 Segment by Type
    4.1 Global Typhoid Fever Vaccines Sales by Type (2019-2030)
        4.1.1 Global Typhoid Fever Vaccines Sales by Type (2019-2024)
        4.1.2 Global Typhoid Fever Vaccines Sales by Type (2025-2030)
        4.1.3 Global Typhoid Fever Vaccines Sales Market Share by Type (2019-2030)
    4.2 Global Typhoid Fever Vaccines Revenue by Type (2019-2030)
        4.2.1 Global Typhoid Fever Vaccines Revenue by Type (2019-2024)
        4.2.2 Global Typhoid Fever Vaccines Revenue by Type (2025-2030)
        4.2.3 Global Typhoid Fever Vaccines Revenue Market Share by Type (2019-2030)
    4.3 Global Typhoid Fever Vaccines Price by Type (2019-2030)

 5 Segment by Application
    5.1 Global Typhoid Fever Vaccines Sales by Application (2019-2030)
        5.1.1 Global Typhoid Fever Vaccines Sales by Application (2019-2024)
        5.1.2 Global Typhoid Fever Vaccines Sales by Application (2025-2030)
        5.1.3 Global Typhoid Fever Vaccines Sales Market Share by Application (2019-2030)
    5.2 Global Typhoid Fever Vaccines Revenue by Application (2019-2030)
        5.2.1 Global Typhoid Fever Vaccines Revenue by Application (2019-2024)
        5.2.2 Global Typhoid Fever Vaccines Revenue by Application (2025-2030)
        5.2.3 Global Typhoid Fever Vaccines Revenue Market Share by Application (2019-2030)
    5.3 Global Typhoid Fever Vaccines Price by Application (2019-2030)

 6 Key Companies Profiled
    6.1 Sanofi Pasteur
        6.1.1 Sanofi Pasteur Corporation Information
        6.1.2 Sanofi Pasteur Description and Business Overview
        6.1.3 Sanofi Pasteur Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 Sanofi Pasteur Typhoid Fever Vaccines Product Portfolio
        6.1.5 Sanofi Pasteur Recent Developments/Updates
    6.2 GlaxoSmithKline
        6.2.1 GlaxoSmithKline Corporation Information
        6.2.2 GlaxoSmithKline Description and Business Overview
        6.2.3 GlaxoSmithKline Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
        6.2.4 GlaxoSmithKline Typhoid Fever Vaccines Product Portfolio
        6.2.5 GlaxoSmithKline Recent Developments/Updates
    6.3 Bharat Biotech
        6.3.1 Bharat Biotech Corporation Information
        6.3.2 Bharat Biotech Description and Business Overview
        6.3.3 Bharat Biotech Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
        6.3.4 Bharat Biotech Typhoid Fever Vaccines Product Portfolio
        6.3.5 Bharat Biotech Recent Developments/Updates
    6.4 PaxVax
        6.4.1 PaxVax Corporation Information
        6.4.2 PaxVax Description and Business Overview
        6.4.3 PaxVax Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 PaxVax Typhoid Fever Vaccines Product Portfolio
        6.4.5 PaxVax Recent Developments/Updates
    6.5 Biomed
        6.5.1 Biomed Corporation Information
        6.5.2 Biomed Description and Business Overview
        6.5.3 Biomed Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
        6.5.4 Biomed Typhoid Fever Vaccines Product Portfolio
        6.5.5 Biomed Recent Developments/Updates
    6.6 Prokarium
        6.6.1 Prokarium Corporation Information
        6.6.2 Prokarium Description and Business Overview
        6.6.3 Prokarium Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
        6.6.4 Prokarium Typhoid Fever Vaccines Product Portfolio
        6.6.5 Prokarium Recent Developments/Updates
    6.7 China National Biotec Group
        6.6.1 China National Biotec Group Corporation Information
        6.6.2 China National Biotec Group Description and Business Overview
        6.6.3 China National Biotec Group Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 China National Biotec Group Typhoid Fever Vaccines Product Portfolio
        6.7.5 China National Biotec Group Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Typhoid Fever Vaccines Industry Chain Analysis
    7.2 Typhoid Fever Vaccines Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Typhoid Fever Vaccines Production Mode & Process
    7.4 Typhoid Fever Vaccines Sales and Marketing
        7.4.1 Typhoid Fever Vaccines Sales Channels
        7.4.2 Typhoid Fever Vaccines Distributors
    7.5 Typhoid Fever Vaccines Customers

 8 Typhoid Fever Vaccines Market Dynamics
    8.1 Typhoid Fever Vaccines Industry Trends
    8.2 Typhoid Fever Vaccines Market Drivers
    8.3 Typhoid Fever Vaccines Market Challenges
    8.4 Typhoid Fever Vaccines Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’